Trial Profile
Interactions between exogenous Insulin Aspart, endogenous insulin and plasma glucose in type 2 diabetes mellitus patients [Interaktioner mellem eksogent Insulin Aspart, endogent insulin og plasma glukose ved type 2 diabetes mellitus]
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary) ; Glucose
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 01 Jan 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 07 Apr 2012 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database record.
- 07 Apr 2012 Actual initiation date (22 Dec 2011) added as reported by European Clinical Trials Database record.